A Phase 2 Study of Venetoclax in Combination With Low-dose HHT, G-CSF, and AZA as First-line Treatment for Newly Diagnosed Elderly AML Patients Unfit for Intensive Chemotherapy

Clinical trial NCT04824924 · UNKNOWN

Trial details

NCT number: NCT04824924
Sponsor: Shanghai Jiao Tong University School of Medicine
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2021-03-01
Primary completion: 2024-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.